The latest announcement is out from HeartBeam ( (BEAT) ).
HeartBeam, Inc. has strengthened its executive team by appointing Timothy Cruickshank as their new Chief Financial Officer, effective September 9, 2024. Cruickshank, with a solid background in financial leadership and experience in medical technology, will earn an annual fee of $385,000 with the possibility of bonuses and stock options. His previous tenure at ImpediMed demonstrated his ability to transition a company to a high-margin SaaS business model, a skill set he is expected to leverage at HeartBeam to drive financial excellence and support the commercialization of their innovative cardiac care technology.
For detailed information about BEAT stock, go to TipRanks’ Stock Analysis page.
